Citigroup Maintains Buy on BeiGene, Raises Price Target to $290
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Yigal Nochomovitz maintains a Buy rating on BeiGene (NASDAQ:BGNE) and raises the price target from $285 to $290.
September 21, 2023 | 2:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Citigroup maintains a Buy rating on BeiGene and raises the price target from $285 to $290, which could potentially increase investor confidence and drive the stock price up.
The raised price target by Citigroup indicates a positive outlook for BeiGene. This could potentially increase investor confidence in the stock, leading to increased demand and a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100